Determination of Risk for Sterile Preparations
Author(s): Freedman ben-Horin Shimon, Rousso Tamaro
Issue: Jan/Feb 2014 - Volume 18, Number 1
View All Articles in Issue
Page(s): 30-34
Download in electronic PDF format for $75
Abstract: A quick and reliable system is described to quantify risk assessment for compounded sterile pharmaceuticals, which are “compounded in anticipation” for hospitals and clinics, having shelf lives assessed on documented literature and other criteria. These shelf lives are well in excess of the recommendations of the United States Pharmacopeia without placing patients at risk due to inadequate safety, quality, or efficacy.
Related Keywords: Shimon Freedman ben-Horin, Bpharm, MRPharmS, PhD, Tamaro Rousso, BPharm, MSc, compounded sterile preparations, risk assessment, compounded in anticipation, sterile compounding, United States Pharmacopeia, USP, scoring system
Related Categories: STERILE PREPARATIONS, QUALITY CONTROL, UNITED STATES PHARMACOPEIA CONVENTIONS